CONTINGENCY MANAGEMENT AND ANTISOCIAL PERSONALITY DISORDER Karen K. Chan 1,3, Alice Huber 1,2,3, John M. Roll 1,3, and Vikas Gulati 1,3 Friends Research.

Slides:

Advertisements

Similar presentations

Gender Differences in Health Status Among Opiate Users in a 25-Year Follow-up Study Christine Grella & Luz Rodriguez UCLA Integrated Substance Abuse Programs.

Advertisements

Aftercare Attendance Partially Moderated by History of Physical Abuse and Gender Louise F. Haynes 1 ; Amy E. Herrin 1 ; Rickey E. Carter 1 ; Sudie E. Back.

Background: The low retention rates among African Americans in substance abuse treatment (Milligan et al., 2004) combined with the limited number of treatments.

Substance Use: Substance use comparisons included lifetime and past 30 day use (Figure 3) and lifetime use. For past 30 day use, more men reported heroin.

Delay from Testing HIV Positive until First HIV Care for Drug Users: Adverse Consequences and Possible Solutions Barbara J Turner MD, MSEd* John Fleishman.

ANTISOCIAL PERSONALITY DISORDER Valerie Llerenas Psychology Period #5.

Antisocial Personality Disorder Helen Cativo Period :3 April 20,2012.

Journal Club Alcohol and Health: Current Evidence November–December 2004.

Challenges and Successes Treating Adolescent Substance Use Disorders Janet L. Brody, Ph.D. Center for Family and Adolescent Research (CFAR), Oregon Research.

Treatment of Methamphetamine Dependence: Does Treatment Work? Mary Lynn Brecht, Ph.D. Richard A. Rawson, Ph.D Semel Institute for Neuroscience and Human.

Chapter 2 The Problem of Dual Diagnosis. Dual Diagnosis and Comorbidity Dual diagnosis – Describes individuals who meet diagnostic criteria for a mental.

® Introduction Low Back Pain Remedies and Procedures: Helpful or Harmful? Lauren Lyons, Terrell Benold, MD, Sandra Burge, PhD The University of Texas Health.

Psychopharmacotherapy in Correctional Institutions Robert P. Schwartz, M.D. Friends Research Institute Supported by NIDA R01 DA (PI: Kinlock)

Low-Cost Contingency Management in Community Settings

Practical Application of Contingency Management Michael J. McCann, MA Matrix Institute on Addictions.

Audrey J. Brooks, PhD University of Arizona CA-AZ node.

Frequency and type of adverse events associated with treating women with trauma in community substance abuse treatment programs T. KIlleen 1, C. Brown.

NIDA Grants: U10DA015831, K24DA022288, U10DA020024, K23DA022297, U10DA Predictors of Outcome in the Multi-Site CTN Prescription Opioid Addiction.

Evidence-Based Practice: Psychosocial Interventions Maxine Stitzer, Ph.D. Johns Hopkins Univ SOM NIDA Blending Conference June 3, 2008 Cincinnati, Ohio.

American Association for the Treatment of Opioid Dependence, Inc National Conference, Atlanta April 25, 2006 Evaluation of the Impact of Opioid Treatment.

Multifinality: Same underlying cause, different disorders. Jeremiah Weinstock, PhD OPG Summit 2014 Berkeley, CA.

Results of the Vivitrol Pilot in Los Angeles County Presented by: Desiree A. Crevecoeur-MacPhail, Ph.D. Research Psychologist, UCLA ISAP.

METHODS Sample n=245 Women, 24% White, 72% Average age, 36.5 Never married, 51% Referral Sources (%) 12-Month DSM-IV Substance Dependence Prior to Entering.

Outcomes of Treatment for Methamphetamine Use: LA County (“Treatment-as-Usual”) M.-L. Brecht UCLA Integrated Substance Abuse Programs CATES 3/30/2004.

Effect of Depression on Smoking Cessation Outcomes Sonne SC 1, Nunes EV 2, Jiang H 2, Gan W 2, Tyson C 1, Reid MS 3 1 Medical University of South Carolina,

A Longitudinal study of the order of onset of alcohol dependence and major depression (Gilman and Abraham, 2001) by Andrew M C Govern Journal presentation:

Contingency management: Using principles of reinforcement to improve drug abuse treatment Nancy Petry, Ph.D. University of Connecticut Health Center Farmington,

Recovery Support Services and Client Outcomes: What do the Data Tell Us? Recovery Community Services Program Grantee Meeting December 14, 2007.

Contingency Management Contingency management (CM) refers to the systematic application of basic principles delineated by workers in the field of the Experimental.

Criminal Justice Referral and Incentives in Outpatient Substance Abuse Treatment Anthony DeFulio 1, Paul Nuzzo 2, & Maxine Stitzer 1 1 – Johns Hopkins.

CCTN September 6 th, Recent Scientific Publications from the Clinical Trials Network David Liu, M.D. (CTN-0029) Harold Perl, Ph.D. (CTN-0015) Paul.

Chapter 16 Addictive Disorders. Abuse  Use of a substance that falls outside of medical necessity or social acceptance resulting in adverse effects to.

Retrospective evaluation of ASAM criteria in adolescents receiving weekly outpatient treatment for co-occurring psychiatric and substance use disorders.

Raymond F. Anton, MD for The COMBINE Study Research Group

Participants were recruited from 6 drug free, psychosocial treatment (PT) and 5 methadone maintenance (MM) programs (N = 628) participating in a NIDA Clinical.

Abstinence Incentives for Methadone Maintained Stimulant Users: Outcomes for Those Testing Stimulant Positive vs Negative at Study Intake Maxine L. Stitzer.

The COMBINE Study: Design and Methodology Stephanie S. O’Malley, Ph.D. for The COMBINE Study Research Group JAMA Vol. 295, , 2006 (May 3 rd.

Introduction Results and Conclusions ATR Results: On demographic and social characteristics, ATR completers were more likely to be Hispanic, employed,

CONDUCT DISORDER By: Takiyah King. Background The IQ debate The IQ debate Impulse control Impulse control Response Inhibition Response Inhibition.

Psychology Psychology is defined as the scientific study of human behavior and mental processes. Subset of psychology is criminal psychology: the study.

Introduction Results and Conclusions Categorical group comparisons revealed no differences on demographic or social variables. At admission to treatment,

Introduction Results and Conclusions On demographic variables, analyses revealed that ATR clients were more likely to be Hispanic and employed, whereas.

Methamphetamine: User Characteristics and Treatment Response Alice Huber, Ph.D. Steven Shoptaw, Ph.D. Richard A. Rawson, Ph.D. Paul Brethen, M.A. Walter.

Abstinence Incentive Effects in Psychosocial Counseling Patients Testing Stimulant Positive vs Negative at Treatment Entry Maxine L. Stitzer Johns Hopkins.

Table 1. Prediction model for maximum daily dose of buprenorphine-naloxone in a 12-week treatment condition Baseline Predictors Maximum Daily Dose Standardized.

Introduction Results and Conclusions Analyses of demographic and social variables revealed that women were more likely to have children, be living in a.

STAR*D Objectives Compare relative efficacy of different treatment options –Goal is REMISSION, not just “response” –Less than half of patients with depression.

® Changes in Opioid Use Over One Year in Patients with Chronic Low Back Pain Alejandra Garza, Gerald Kizerian, PhD, Sandra Burge, PhD The University of.

Texas COSIG Project Gender Differences in Substance Use Severity and Psychopathology in Clients with Co-Occurring Disorders 5 th Annual COSIG Grantee Meeting.

Combined Pharmacological and Behavioral Therapy and HIV Risk Reduction Jennifer Schroeder, David Epstein, Katherine Belendiuk, Jessica Willner-Reid, John.

Baseline Characteristics by Primary Substance of Abuse of Outpatient Clients in a Web-based Intervention Trial Aimee N. C. Campbell, Ph.D. 1,2,3, Edward.

Ten Years of Pharmacotherapy Trials in the CTN: An Overview.

Predictors of study retention in addiction treatment trials KORTE JE 1, MAGRUDER KM 1,2, KILLEEN TK 1, SONNE SC 1, SAMPSON RR 1 and BRADY KT 1,2 1. Medical.

Introduction to Forensic Psychology Seminar 2 Dr. Marc T. Zucker, Psy.D.

Introduction Results and Conclusions Comparisons of psychiatric hospitalization rates in the 12 months prior to and after baseline assessment revealed.

BEHAVIORAL FAMILY COUNSELING AND NALTREXONE FOR MALE OPIOID-DEPENDENT PATIENTS William Fals-Stewart, Ph.D. Research Institute on Addictions.

Introduction Results and Conclusions Analyses of demographic and social variables indicated that Hispanics were more likely to be male, married, and living.

Practical Application of Contingency Management Michael J. McCann, MA Matrix Institute on Addictions.

What the National Institute on Drug Abuse’s Clinical Trials Network Can Do for You? Major Findings from Medication Trials and Implications for Community-Based.

Introduction Results and Conclusions Numerous demographic variables were found to be associated with treatment completion. Completers were more likely.

Randomized Controlled CTN Trial of OROS-MPH + CBT in Adolescents with ADHD and Substance Use Disorders Paula Riggs, M.D., Theresa Winhusen, PhD., Jeff.

Table 2. Characterization of the Pubmed data base’s articles included in the sample Selene Cordeiro Vasconcelos et al. Psychiatrics Disorders in Crack.

Medication Adherence and Substance Abuse Predict 18-Month Recidivism among Mental Health Jail Diversion Program Clients Elizabeth N. Burris 1, Evan M.

Association of Cognitive Outcomes and Response Status in Late Life Depression: A 12 Month Longitudinal Study David Bickford B.A., Alana Kivowitz B.A.,

Table 1. Characterization of the SCOPUS data base’s articles included in the sample Selene Cordeiro Vasconcelos et al. Psychiatrics Disorders in Crack.

Methadone maintenance in Michigan: Five years of data using a contingency management approach Gary Rhodes, M.A., L.L.P. Golfo Tzilos, M.A. Mark Greenwald,

Date of download: 6/27/2016 Copyright © 2016 American Medical Association. All rights reserved. From: A Comparison of Contingency Management and Cognitive-Behavioral.

Predictors of study retention in drug abuse treatment trials

Results: Specific Aim 2 (cont.)

The relationship between incarceration and opioid addiction treatment

Presentation transcript:

CONTINGENCY MANAGEMENT AND ANTISOCIAL PERSONALITY DISORDER Karen K. Chan 1,3, Alice Huber 1,2,3, John M. Roll 1,3, and Vikas Gulati 1,3 Friends Research Institute, Inc. 1 Long Beach Research Foundation: VAMDRU 2 UCLA Integrated Substance Abuse Programs 3 Address correspondence to

Abstract Contingency management (CM), a behavioral reinforcement technique, has been shown to be effective in the treatment of cocaine dependence, and there is emerging data on its effectiveness for methamphetamine (MA) dependence. The prevalence of Antisocial Personality Disorder (ASPD) is considerably higher in drug-abusing populations than in the general population and the outcome of traditional therapies should be evaluated separately for that subpopulation. A recent report indicated that opiate and cocaine abusers with ASPD responded particularly well to a CM program (Brooner et al., 1999). This report examines whether the efficacy of CM as a treatment for MA dependence differs depending on the co-occurrence of ASPD. Data from 166 participants in a NIDA-funded study evaluating medication and CM as MA treatments were examined to consider how ASPD affects the efficacy of CM. 37% (N=61) were diagnosed with ASPD as determined by the Structured Clinical Interview for DSM-IV Diagnoses (SCID). Those randomized to the CM condition achieved significantly longer periods abstinence that those individuals randomized to no CM regardless of ASPD diagnoses. These findings suggest that CM can be a powerful intervention in the treatment of MA dependence and that this effect may be independent of ASPD diagnoses.

Introduction Contingency Management (CM) = vouchers are awarded for drug-free urine analyses. When combined with drug abuse counseling, CM can be effective in assisting stimulant dependent individuals towards abstinence. In methadone maintained patients, take-home doses were contingent on drug-free urine analyses. Patients with CM had longer rates of abstinence from opiates than the control group (Iguchi, Stitzer, Bigelow, Liebson & 88; Magura, Casriel, Goldsith, Sturg & Lipton, 88). CM was beneficial in the treatment of cocaine abuse. Participants receiving vouchers and counseling had a longer abstinence than participants receiving only counseling (Silverman, Higgins, Brooner, Montoya, Cone, Schuster, & Preston, 1996). Of CM cocaine abusers that had a poorer outcome in treatment, more had Antisocial Personality Disorder (ASPD) (Schuster, Silverman, Harrell, Brooner, Cone, & Preston, 1995). Individuals with ASPD responded better to CM than ASPD individuals without CM (Brooner, 1998).

ASPD Definition Definition Antisocial personality disorder is characterized by a lack of regard for the moral or legal standards in the local culture. There is a marked inability to get along with others or abide by societal rules. Individuals with this disorder are sometimes called psychopaths or sociopaths. Diagnostic Criteria ( DSM-IV ) 1. Since the age of fifteen there has been a disregard for and violation of the rights of others, those rights considered normal by the local culture, as indicated by at least three of the following: A. Repeated acts that could lead to arrest. B. Conning for pleasure or profit, repeated lying, or the use of aliases. C. Failure to plan ahead or being impulsive. D. Repeated assaults on others. E. Reckless when it comes to their or others safety. F. Poor work behavior or failure to honor financial obligations. G. Rationalizing the pain they inflict on others. 2. At least eighteen years in age. 3. Evidence of Conduct Disorder, with onset before the age of fifteen. 4. Symptoms not due to another mental disorder.

Previous Research ArticlePopulationN% N w/ ASPD (Barber et al., 96)Cocaine men & women (outpatient)289 20% (Flynn et al. ’96)All Substances (DATOS in & outpat. men & women) Alcohol Heroin Heroin & Alcohol Cocaine Cocaine & Alcohol Cocaine & Heroin Cocaine, Heroin, & Alcohol % 34.7% 27% 46.3% 30.4% 47% 44% 59.8% (Brooner et al. ‘98)Opiate men & women (outpatient)716 25% (Kessler et al., ’94; Regier et al., ’90; Robins et al., ’91) General Population %

Methods -Drug Cessation Groups -Screening Period -Baseline Data Collection Urn Randomization -CM vs. NO CM -Zoloft (Sertraline) vs. Placebo (Double-blind study) -Relapse Prevention Groups -Weekly Data Collection Weeks Weeks 1-12Weeks 13, 26, 52 -Follow-up Interviews

Sample Characteristics N=166% Gender Males Females % 43% Ethnicity  White  Hispanic  Other % 24% 1%  ASPD  No ASPD % 63%

Measures Urine samples (collected 3x/wk) were screened for methamphetamine and cocaine; screened for marijuana opiates, and benzodiazepines weekly. ASPD determined by the Structured Clinical Interview for DSM-IV Diagnoses (SCID) Longest abstinence (longest period of stimulant-free days based on urinanalysis results) TES scores (total # of urine tests clean) (12 weeks of treatment) x (3 urine tests)=36 Percent urine tests clean (# clean/# submitted) Retention in Treatment (number of days in treatment)

Research Questions Does CM influence: 1. Longest abstinence 2. Treatment Effectiveness Scores 3. Percent clean urine tests 4. Retention in treatment And, does CM work differently for patients with ASPD?

Longest Abstinence  CM significantly improved longest abstinence (F=13.6, d.f.=162, p<.0001).  The effect of ASPD was not statistically significant (ns).  No interaction was present between ASPD and CM (ns).

TES  CM significantly improved TES (F=4.4, d.f.=1, p<.05).  No effect of ASPD (ns).  ASPD and CM interaction not significant (ns).

Percent Clean & Retention Percent Clean  No effect of CM or ASPD (ns).  No significant interaction of ASPD and CM (ns). Treatment Retention  CM did not affect retention (ns).  Diagnosis of ASPD did not affect retention (ns).  No significant interaction (ns).

Longest Abstinence Colors represent length of longest abstinence. Distribution did not vary due to ASPD status, but differed according to CM status. This suggests that participants with ASPD achieved abstinence comparable to those without ASPD.

Conclusions CM significantly lengthened period of longest abstinence and improved TES. CM did not affect percent clean urine samples and treatment retention. CM seems to work equally well in individuals with ASPD, compared to individuals without ASPD.

Implications CM, combined with counseling, can be an effective treatment for methamphetamine (MA) dependence. ASPD is very prevalent in this MA population. CM may be effective in individuals with co-morbid psychiatric conditions.

Implications (2) Regardless of ASPD diagnosis, clients achieved comparable levels of abstinence and have similar rates of retention, suggesting individuals with ASPD perform as well as those without ASPD in treatment. The above findings are in contrast to previous research linking ASPD to poorer CM effectiveness (see introduction).

References Barber, J.P., Frank, A., Weiss, R.D., Blaine, J., Siqueland, L., Moras, K., Calvo, N., Chittams, J., Mercer, D., Salloum, I.M. (1996). Prevalence and correlates of personality disorder diagnoses among cocaine dependent outpatients. Journal of personality disorders, 10 (4), Brooner, R.K., Kidorf, M., King, V.L., Stoller, K. (1998, February). Preliminary evidence of good treatment response in antisocial drug abusers. Drug and Alcohol Dependence, 49 (3), Flynn, P.M., Craddock, S.G., Luckey, J.W., Hubbard, R.L., Dunteman, G.H. (1996). Comorbidity of antisocial personality and mood disorders among psychoactive substance-dependent treatment clients. Journal of Personality Disorders, 10 (1), Iguchi, M.Y., Stitzer, M.L., Bigelow, G.E., Liebson, I.A. (1988). Contingency management in methadone maintenance: Effects of reinforcing and aversive consequences on illicit polydrug use. Drug and Alcohol Dependence, 22, 1-7. Magura, S., Castriel, C., Goldsmith, D., Strug, D.L., & Lipton, D.S. (1988). Contingency contracting with polydrug-abusing methadone patients. Addictive Behaviors, 13, Rawson, R.A., McCann, M.J., & Huber, A. (1995). Contingency management and relapse prevention for primary cocaine users and cocaine-using methadone patients. Paper presented at NIDA Workshop on the behavioral management of drug abuse. Bethesda, MD, 9/14/95. Schuster, C.R., Silverman, K., Harrell, S., Brooner, R., Cone, E., & Preston, K. (1995, December). ASP as a predictor of treatment outcome in a contingency management program for cocaine abusers. Poster presented at the annual meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico. Silverman, K., Higgins, S.T., Brooner, R.K., Montoya, I.D., Cone, E.J., Schuster, C.R., & Preston, K.L. (1996). Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Arch Gen Psychiatry, 53,